GlassScriptPhysician profile
Nathan R Mauren
NPI 1669968459
$11,865.87
in general payments reported to CMS, 2019-2025
29 companies · $1,763 in 2025
The $1,763 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,987 · 2020: $891 · 2021: $2,513 · 2022: $1,351 · 2023: $1,441 · 2024: $919 · 2025: $1,763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,398 · Travel and Lodging: $1,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,397.86 |
| Travel and Lodging | $1,724.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,976.03 | 2019-2025 | Inbone, Prostep Mica, Infinity Adaptis |
| Wardlow Enterprises | $1,563.78 | 2021-2023 | |
| Medical Device Business Services, INC. | $921.97 | 2019-2021 | |
| Orthofix Medical, INC. | $675.44 | 2019 | |
| Integra Lifesciences Corporation | $518.02 | 2020-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Wright Medical Technology, INC. | $421.02 | 2019-2020 | |
| Smith+Nephew, INC. | $313.50 | 2023-2025 | Grafix Pl, Stravix Pl, Oasis |
| Treace Medical Concepts, INC. | $294.60 | 2022-2025 | |
| Arthrex, INC. | $200.40 | 2023 | |
| Organogenesis INC. | $137.71 | 2019-2024 | Puraply |
| Depuy Synthes Sales INC. | $124.72 | 2024 | N/A |
| Misonix INC | $124.25 | 2020 | |
| Polynovo North America LLC | $99.77 | 2024-2025 | Novosorb Btm |
| Zimmer Biomet Holdings, INC. | $93.08 | 2020 | |
| Melinta Therapeutics, LLC | $50.83 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $43.69 | 2021 | |
| Kci USA, INC. | $39.23 | 2023 | Prevena, V.A.C. Dermatac, Activ.A.C. |
| Acera Surgical, INC. | $34.89 | 2019-2021 | |
| Kerecis Limited | $31.51 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Convatec INC. | $26.43 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $24.80 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $23.66 | 2024 | |
| Averitas Pharma INC. | $21.76 | 2023 | Qutenza |
| Carbofix Orthopedics INC | $21.46 | 2023 | |
| Medline Industries LP | $18.97 | 2020 | |
| Solventum Corporation | $17.96 | 2024 | Activ.A.C. |
| Tactile Systems Technology INC | $17.25 | 2021 | |
| Zimvie INC. | $16.27 | 2023 | |
| Novo Nordisk INC | $12.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Mauren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.